Radiodermatitis Market - Global Industry Analysis

Radiodermatitis Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2026

Category: Healthcare Report Format : PDF Report Code: ZMR-6317 Status : Upcoming

Description

Global Radiodermatitis Market: Overview

Radiodermatitis is a cutaneous reaction that is caused by radiation therapy involved in the cancer treatment process. Radiodermatitis is found in the majority of patients receiving treatment for sarcoma, lung cancer, skin cancer, neck cancer, head cancer, breast cancer, and many others. It is also known as radiation dermatitis. The cumulative regular doses of radiation in the treatment process on a target site in the body induces normal skin repopulation and thus it fades skin integrity around the target site. However, radiation dermatitis can be chronic as well as acute. It also involves necrosis, fibrosis, hair loss, skin peeling, localized erythema, and several other issues at the target site. Radiodermatitis is treated with different topical agents namely, oral medications, anti-inflammatory agents, oral analgesics, oral corticosteroids, topical antibiotics, hydrophilic creams, and dressings.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Global Radiodermatitis Market: Growth Factors

One of the major factors driving the growth of the global radiodermatitis market is the growing incidences of cancer all around the world. Cancer patients are more vulnerable to radiation-induced skin reactions or radiodermatitis which affects the quality of life and physical functioning of the human body. Such adverse effects of radiodermatitis boost the demand for its treatment products in the market globally. However, the growing cases of obesity all across the globe due to the sedentary lifestyle, lack of physical activity, and poor dietary habits further contribute towards the growth of cancer cases all across the globe. In obese people, a larger area of skin is exposed to radiation therapy and hence has a greater chance of damages to the skin tissues, wounds, and improper blood supply that causes skin abrasions in patients. Moreover, the growing tobacco and smoking usages are other factors escalating the incidences of cancer. All such emerging scenarios will significantly project the growth of the global radiodermatitis market vigorously during the forecast period. The growing investments from government and prominent market players to boost the research activities and develop innovative drugs that can effectively treat the cases of radiodermatitis in patients further accelerate the growth of the market globally.

Global Radiodermatitis Market: Segmentation

The global radiodermatitis market can be segmented into the distribution channel, product, and region.

By distribution channel, the market can be segmented into retail pharmacy, hospital pharmacy, and online pharmacy. The retail pharmacy segment accounts for the largest share in the global radiodermatitis market due to the high availability of affordable options in the local markets. Moreover, the availability of more generic drugs coupled with its cost-effective benefit further boosts the growth of the segment. However, the online pharmacy segment is anticipated to witness huge growth during the forecast period due to the convenience offered by online platforms as it facilitates home delivery to people. Moreover, the discounts offered by online pharmacies also attract customers.

By product, the market can be segmented into dressings, oral drugs, and topical medications. The topical segment holds the largest share in the global radiodermatitis market due to its bioavailability, cost-effectiveness, and easier application. However, the dressing segment is expected to witness huge growth during the forecast period due to the availability of a wide range of dressing products.

Global Radiodermatitis Market: Regional analysis

Asia Pacific accounts for the largest share in the global radiodermatitis market due to the growing disposable income of people. Moreover, the growing expenditure from government authorities and prominent market players to strengthen the healthcare infrastructure will also boost the growth of the regional market during the forecast period.

North America is anticipated to witness huge growth during the forecast period due to the growing incidences of cancer in the region. Also, the significant spike in the demand for radiation therapy coupled with convenient reimbursement healthcare policy propels the growth of the regional market during the forecast period.

Global Radiodermatitis Market: Competitive Players

Some of the significant players in the global radiodermatitis market are Derma Sciences Inc., 3M Healthcare, Molnlycke Health Care AB, InterMed, Alliqua BioMedical, Acelity L.P. Inc., BMG PHARMA S.p.A., ConvaTec Inc., Smith & Nephew plc, and Stratpharma AG.

Global Radiodermatitis Market: Regional Segment Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Table Of Content

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

One of the major factors driving the growth of the global radiodermatitis market is the growing incidences of cancer all around the world. Cancer patients are more vulnerable to radiation-induced skin reactions or radiodermatitis which affects the quality of life and physical functioning of the human body.

Some of the significant players in the global radiodermatitis market are Derma Sciences Inc., 3M Healthcare, Molnlycke Health Care AB, InterMed, Alliqua BioMedical, Acelity L.P. Inc., BMG PHARMA S.p.A., ConvaTec Inc., Smith & Nephew plc, and Stratpharma AG.

Asia Pacific accounts for the largest share in the global radiodermatitis market due to the growing disposable income of people. Moreover, the growing expenditure from government authorities and prominent market players to strengthen the healthcare infrastructure also boosts the growth of the regional market during the forecast period.

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed